EverGlade Consulting in the Media

 In a move to secure America’s leadership in the semiconductor sector, the U.S. Department of Commerce (DoC) announced on Friday, the start of its rolling pre-application process for large-scale supply chain projects and wafer manufacturing facilities.

 In response to the increasing complexity of the space environment, the Defense Innovation Unit (DIU), has announced its pursuit of innovative commercial solutions for the development of Tactically Responsive Space (TacRS) systems.

The Biden Cancer Moonshot has announced a pioneering program under the Advanced Research Projects Agency for Health (ARPA-H) to develop innovative technologies to enhance the precision and accuracy of tumor removal in cancer surgeries.

Eric Jia-Sobota, Founder of EverGlade Consulting (“EverGlade”), is excited to announce a significant shift in EverGlade’s marketing strategy and the launch of a new advertising campaign.

The National Institute of Allergy and Infectious Diseases (NIAID) recently released a Notice of Special Interest (NOSI) aimed at encouraging research proposals on targeted protein and nonprotein degradation for the development of anti-infective strategies against viral, bacterial, and fungal pathogens and toxins. 

As EverGlade Consulting passes its three-year milestone, supplier diversity is quickly becoming the cornerstone to a new era of diversity, equity, and inclusion in today’s evolving business ecosystem. Visibility and representation have been shown to be marked characteristics that foster more inclusivity and advance equitable agendas within businesses, organizations, and even governmental entities.

The Fiscal Responsibility Act of 2023 aims to reduce USG spending by $2.1 trillion, with an additional $1.5 trillion in mandated savings over the next two years. The bill reclaims $28 billion of unutilized COVID-19 funds and cuts an additional $400 million from the CDC’s “Global Health Fund,” which channels taxpayer funds to China. Collectively, these cuts represent the largest rollback of federal spending in American history.

In the latest amendment to its Broad Agency Announcement (BAA), BARDA (Biomedical Advanced Research and Development Authority) is seeking proposals for the development of cost-effective and adaptable therapeutic platforms to treat viral infections, as well as next-generation COVID-19 vaccines.

The United States Economic Development Administration (EDA) released a Notice of Funding Opportunity (NOFO) for Regional Technology and Innovation Hubs (Tech Hubs). This initiative aims to foster innovation, collaboration, and economic growth by establishing regional technology hubs across the nation by providing funding and resources to create and expand technology-focused hubs.

EverGlade Consulting (“EverGlade”), a national consulting firm, has helped Appili Therapeutics USA Inc. (“Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, secure an initial contract with the U.S. Air Force Academy (USAFA). USAFA is the prime contractor to DTRA for this program. 

CHARLESTON, S.C., April 12, 2023 /PRNewswire/ — Project Next Gen is a new program launched by the Biden administration aimed at accelerating the development of new coronavirus vaccines and treatments.

The US Department of Commerce has opened the application process for companies to revitalize the domestic semiconductor industrial base. The move is aimed at securing a share of the multi-billion-dollar semiconductor opportunity by 2030 and strengthening leadership in chip manufacturing.